A 77-Year-Old Male Patient with a History of Benign Prostatic

A 77-year-old male patient with a history of benign prostatic hyperplasia treated with finasteride has routine laboratory revealing a prostate specific antigen (PSA) of 7.5 ng/mL. Which of the following must be considered in interpreting this finding?

A) Finasteride is associated with a 50% decrease in prostate cancer risk
B) Finasteride is associated with a 50% increase in prostate cancer risk
C) Finasteride is associated with a 50% decrease in PSA
D) Finasteride is associated with a 50% increase in PSA